Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites
Top Cited Papers
Open Access
- 12 July 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (17), 7346-7359
- https://doi.org/10.1021/jm300346w
Abstract
Bromodomains are readers of the epigenetic code that specifically bind acetyl-lysine containing recognition sites on proteins. Recently the BET family of bromodomains has been demonstrated to be druggable through the discovery of potent inhibitors, sparking an interest in protein-protein interaction inhibitors that directly target gene transcription. Here, we assess the druggability of diverse members of the bromodomain family using SiteMap and show that there are significant differences in predicted druggability. Furthermore, we trace these differences in druggability back to unique amino acid signatures in the bromodomain acetyl-lysine binding sites. These signatures were then used to generate a new classification of the bromodomain family, visualized as a classification tree. This represents the first analysis of this type for the bromodomain family and can prove useful in the discovery of inhibitors, particularly for anticipating screening hit rates, identifying inhibitors that can be explored for lead hopping approaches, and selecting proteins for selectivity screening.Keywords
Funding Information
- Wellcome Trust
- GlaxoSmithKline
- Pfizer
- Takeda Pharmaceuticals North America
- Canada Foundation for Innovation
- Novartis
- Canadian Institutes of Health Research
- Cancer Research UK
- Abbott Laboratories
- National Institute for Health Research
This publication has 34 references indexed in Scilit:
- Discovery and Characterization of Small Molecule Inhibitors of the BET Family BromodomainsJournal of Medicinal Chemistry, 2011
- A Small Molecule Binding to the Coactivator CREB-Binding Protein Blocks Apoptosis in CardiomyocytesCell Chemical Biology, 2011
- Predicting protein druggabilityDrug Discovery Today, 2005
- An inhibitor of Bcl-2 family proteins induces regression of solid tumoursNature, 2005
- Selective Small Molecules Blocking HIV-1 Tat and Coactivator PCAF AssociationJournal of the American Chemical Society, 2005
- Ligand efficiency: a useful metric for lead selectionDrug Discovery Today, 2004
- The druggable genomeNature Reviews Drug Discovery, 2002
- Bromodomain: an acetyl‐lysine binding domainFEBS Letters, 2002
- Translating the Histone CodeScience, 2001
- The Protein Data BankNucleic Acids Research, 2000